One strategy that I’ve found effective when introducing a new drug to a skeptical physician is delayed value setting. Many times I see folks lead with a robotic sales pitch before understanding how to portray value directly. By approaching a physician with a consultative approach, you are able to analyze the potential benefits of the drug for that specific physician and more importantly their patients.
A Data-Driven Approach to Introducing New Pharmaceuticals In the challenging realm of pharmaceutical sales, my go-to strategy involves steering through skepticism with a data-driven narrative. By arming myself with compelling clinical evidence and tangible patient outcomes, I not only present a persuasive case but also initiate open conversations with physicians. Understanding their concerns and tailoring my approach to address specific needs fosters trust. This strategy not only breaks down skepticism but also establishes a foundation for collaborative decision-making, allowing the merits of a new drug to shine in the light of empirical support.